Personalized Medicine

NIH Launches AI, Medical Imaging Center to Combat COVID-19

by Jessica Kent

NIH has launched the Medical Imaging and Data Resource Center (MIDRC), which will utilize artificial intelligence and medical imaging to enhance COVID-19 detection and treatment. For more coronavirus...

Deep Learning Algorithm Could Enhance Genomic Sequencing

by Jessica Kent

A deep learning tool could improve genomic sequencing processes, identifying disease-causing mechanisms that might otherwise be missed by traditional screening methods, according to a study published...

Precision Medicine Research Project Focuses on Rare Cancers

by Jessica Kent

TargetCancer Foundation (TCF) has announced the Target Rare Cancer Knowledge (TRACK) study, an initiative that leverages genomic analysis and precision medicine to provide patients and providers with...

Genome Analytics Could Boost Precision Medicine for Kidney Cancer

by Jessica Kent

Scientists at City of Hope and the Translational Genomics Research Institute (TGen) are accelerating precision medicine and personalized treatments for kidney cancer using an advanced genome analytics...

How Precision Medicine, Genomics Research is Decoding COVID-19

by Jessica Kent

Since COVID-19 has entered and spread across the US, healthcare researchers have aimed to learn everything they can about the virus. For more coronavirus updates, visit our resource page, updated...

Team Uncovers Genetic Variants that Impact COVID-19 Susceptibility

by Jessica Kent

Genetic variants may play a role in a person’s susceptibility to COVID-19, leading to a better understanding of which populations are most at risk of severe complications from the virus,...

Biomarker Can Detect, Predict Severity of Traumatic Brain Injury

by Jessica Kent

Neurofilament light chain as a blood biomarker can detect brain injury and predict recovery in different groups, including professional hockey players with acute or chronic concussions, according to a...

Gene Variants May Advance Cancer Precision Medicine for Black Men

by Jessica Kent

Newly identified gene variants could possibly lead to precision medicine prostate cancer therapies specifically for black men. Black men in the US are known to disproportionately suffer from prostate...

Genome Mapping Method Could Accelerate Precision Medicine for Lupus

by Jessica Kent

Researchers from Children’s Hospital of Pennsylvania (CHOP) leveraged a new genome mapping approach to pinpoint two new possible therapeutic targets for lupus, while also accurately identifying...

Researchers Discover Genetic Variants Linked to Type 2 Diabetes

by Jessica Kent

In the largest study of its kind, researchers discovered hundreds of novel genetic variants linked to type 2 diabetes, potentially improving care for millions living with this disease. A team from the...

New Imaging Analytics Method May Boost Schizophrenia Treatment

by Jessica Kent

An innovative imaging analytics method helped researchers categorize subgroups of schizophrenia patients using functional magnetic resonance imaging (fMRI) data, according to a study published in...

Predictive Analytics Models Determine Diabetes Life Expectancy

by Jessica Kent

Building predictive models with patient data – such as history of comorbidities and medications – can determine the five- to ten-year life expectancy of older people with diabetes and help...

Johns Hopkins Leverages Microsoft AI for Precision Medicine

by Jessica Kent

Johns Hopkins Medicine (JHM) and Microsoft Azure have announced a partnership to leverage Microsoft’s artificial intelligence and analytics tools for accelerated precision medicine...

“All of Us” Opens Precision Medicine Data Platform for Beta Testing

by Jessica Kent

The All of Us precision medicine research program has opened its data platform for beta testing, allowing investigators to offer feedback on its preliminary resources. The All of Us Researcher...

Precision Medicine Informs Cost-Effective Heart Disease Treatments

by Jessica Kent

Using precision medicine approaches to tailor heart disease therapies could lead to more cost-effective treatments and improved patient outcomes, according to a study led by researchers at the...

Genomic Data Collaboration to Aid Precision Medicine, Drug Discovery

by Jessica Kent

The Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus is partnering with the Regeneron Genetics Center (RGC) to advance precision medicine and drug...

Gene Linked to Cholesterol Regulation Could Boost Precision Medicine

by Jessica Kent

A team from the University of Wisconsin-Madison has uncovered a gene involved in regulating the body’s cholesterol, which could help advance precision medicine treatments for heart disease and...

Risk Scores Predict Patients Likely to Develop Multiple Infections

by Jessica Kent

Certain risk scores already used to evaluate the severity of a trauma patient’s condition can also help providers determine which patients are highly likely to develop multiple infections,...

New Data Repository Could Speed Precision Medicine for Cancer

by Jessica Kent

The National Cancer Institute (NCI) has launched the Proteomic Data Commons (PDC), a next-generation proteomic data repository that will facilitate data access, sharing, and analysis, and speed the...

More Than 50% of People Expect Compensation for Genomic Data Sharing

by Jessica Kent

Once people are aware of the issues surrounding genomic data sharing, collection, and security, individuals are more concerned with how their information will be used and expect to receive compensation...